Yael Gothelf
Chief Tech/Sci/R&D Officer chez BRAINSTORM CELL THERAPEUTICS INC.
Profil
Yael Gothelf is currently the Vice President of Scientific & Regulatory Affairs at Brainstorm Cell Therapeutics, Inc. since 2007.
Prior to this, Yael worked as a Scientific Manager for Research & Process Development at Interpharm Laboratories Ltd.
Yael holds a doctorate degree from Tel-Aviv University.
Postes actifs de Yael Gothelf
| Sociétés | Poste | Début |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/01/2007 |
Anciens postes connus de Yael Gothelf
| Sociétés | Poste | Fin |
|---|---|---|
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The private company is based in Rehovot, Israel. The company was founded by Israel Makov. | Chief Tech/Sci/R&D Officer | - |
Formation de Yael Gothelf
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The private company is based in Rehovot, Israel. The company was founded by Israel Makov. | Health Technology |
